2008 |
|
| 17 March | New executives appointed in senior, global roles Quiescence Technologies accelerating compound development towards commercialization ... Quiescence Technologies LLC has appointed three new senior executives in global roles to support its next phase of growth. More >> |
| 07 February | QSB anti-virulence platform inhibits biofilm formation by Staphylococcus aureus MRSA and Candida sp. Quiescence Technologies LLC has generated preliminary in-vitro data indicating high efficacy of selected Quorum Sensing Blockers ("QSB") in inhibiting biofilm ... More >> |
2007 |
|
| 11 December | Quorum sensing blocker technology milestone in the development of a new treatment for wound-related bacterial infections Quiescence Technologies LLC has achieved an important, early-stage milestone in the development of a new treatment for wound-related bacterial infections... More >> |
2006 |
|
| 28 December | XL TechGroup creates its fifth company, Quiescence Technologies XL TechGroup, Inc. is pleased to announce the creation of Quiescence Technologies LLC, the fifth company to reach the development stage of XL TechGroup's proven methodology for value creation. More >> |
Quiescence Technologies™ LLC was established in December 2006 by XL Tech Group, Inc.